resveratrol has been researched along with Liver Neoplasms in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.12) | 18.2507 |
| 2000's | 23 (25.84) | 29.6817 |
| 2010's | 41 (46.07) | 24.3611 |
| 2020's | 24 (26.97) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Q; Guo, X; Lin, T; Liu, J; Wang, G; Xu, Y; Yao, X; Zeng, J; Zhang, XK | 1 |
| Coussons, PJ; D'Arcy, MS; Pike, CVS | 1 |
| El-Kamel, AH; El-Melegy, MG; Eltaher, HM; Gaballah, A | 1 |
| Berchtold, S; Burkard, M; Busch, C; Frank, J; Lauer, UM; Leischner, C; Marongiu, L; Michel, A; Niessner, H; Venturelli, S | 1 |
| Hu, X; Li, J | 1 |
| Huang, P; Lu, X; Pan, Z; Song, F; Zhang, Q; Zhang, Y | 1 |
| Ezhilarasan, D; Lakshmi, T | 1 |
| Jia, R; Li, J; Qian, Y; Tian, X; Zheng, Y | 1 |
| Amiri, MS; Ghorani-Azam, A; Haddad-Mashadrizeh, A; Hashemzadeh, A; Iriti, M; Mashreghi, M; Mottaghipisheh, J; Nadaf, M; Nourbakhsh, F; Qayoomian, M; Taghavizadeh Yazdi, ME; Vitalini, S | 1 |
| Ene, AG; Ficai, A; Ficai, D; Vladu, AF | 1 |
| Adamiec-Organisciok, M; Dziedzic, A; Filipec-Kanizaj, T; Grgurevic, I; Hudy, D; Jagodzinski, M; Kukla, M; Los, L; Nackiewicz, J; Skladany, L; Skonieczna, M | 1 |
| Ding, H; Han, L; Li, S; Pu, W; Shao, Y; Wang, T; Yin, S; Yu, H; Zhou, S | 1 |
| Azadbakht, O; Behrouj, H; Ghojoghi, R; Moghadam, D; Sabaghan, M; Vakili, S; Veisi, A; Zarei, R; Zarezade, V | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| ALkharashi, NA | 1 |
| Deng, J; Li, Z; Long, L; Luo, T; Peng, X; Wang, Y; Wang, Z; Zhang, H; Zhuo, L | 1 |
| Deng, J; Hao, L; Hu, X; Li, S; Zhang, J | 1 |
| Bajaj, S; Bansal, H; Fayaz, F; Kumar, S; Manchanda, S; Pottoo, FH | 1 |
| Chen, Y; Fu, S; Lu, Y; Luo, J; Wang, BQ; Wen, Q; Wu, J; Wu, Z; Xiong, K; Zhang, Y | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Dai, H; Hu, X; Li, M; Su, J; Sun, X; Wang, P; Wang, X; Yang, W; Zhao, M | 1 |
| Chen, Y; Dai, Z; Huang, H; Liang, CL; Liu, H; Qiu, F; Zhang, Q; Zheng, F | 1 |
| Afzal, O; Al-Abbasi, FA; Alenezi, SK; Alfawaz Altamimi, AS; Alhalmi, A; Almalki, WH; Barkat, MA; Beg, S; Choudhry, H; Kazmi, I; Kumar, V; Rahman, M | 1 |
| Bohara, R; Dhamecha, D; Jadhav, K; Jagwani, S; Jalalpure, S | 1 |
| Aishwarya, TS; Baby, J; Devan, AR; Gorantla, JN; Kumar, AR; Nair, B; Nath, LR | 1 |
| Gao, W; Luo, C; Ma, L; Man, S; Yan, M; Zhao, G | 1 |
| Cho, S; Kim, JR; Lim, J; Park, S | 1 |
| Chen, K; Chen, M; Li, J; Li, X; Wang, G; Wei, G; Yan, Y; Zhou, C | 1 |
| Deng, Y; Feng, Z; Huang, Y; Lian, B; Wang, L; Wu, M; Wu, W; Zhao, X; Zhong, C; Zu, C | 1 |
| Abdel-Bar, HM; El Basset Sanad, RA | 1 |
| Damoiseaux, R; France, B; Gbadegesin, MA; Gimzewski, JK; Odunola, OA; Olugbami, JO; Onibiyo, EM; Sharma, S | 1 |
| Jiang, Q; Qu, Z; Yang, M; Zhang, Q; Zhou, J | 1 |
| Chai, R; Fu, H; Ji, S; Li, G; Liu, T; Zheng, Z | 1 |
| Chen, G; Li, X; Liu, Y; Luo, Y; Tong, L; Wang, Y | 1 |
| Hasegawa, K; Inagaki, Y; Rong, L; Sakamoto, Y; Sawakami, T; Song, P; Tang, W; Xia, J | 1 |
| Cai, W; Han, R; Huang, S; Li, M; Meng, Q; Wang, H; Wu, X; Yang, Z; Zhao, Y | 1 |
| Gao, Y; Li, Y; Liu, Z; Peng, Q | 1 |
| Anwar, DM; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Kamal, MK; Khattab, SN | 1 |
| Sui, S; Yin, X; Zhang, B | 1 |
| Berk, K; Chabowski, A; Charytoniuk, T; Drygalski, K; Harasim-Symbor, E; Konstantynowicz-Nowicka, K; Polak, A | 1 |
| Huang, C; Li, Z; Zeng, J; Zhang, D; Zhang, J; Zhao, X; Zuo, H | 1 |
| Deng, Y; Feng, Z; Lian, B; Wu, M; Zhao, X; Zhong, C | 1 |
| Chen, TY; Chiou, HL; Hsieh, MJ; Lin, CW; Lin, PY; Yang, SF; Yeh, CB | 1 |
| Bu, L; Chen, FZ; Gan, LC; Gou, XJ; Guo, XQ; Hou, SX; Song, Q; Yao, Q | 1 |
| Fernandez-Ramos, D; Li, TW; Lu, SC; Martínez-Chantar, ML; Mato, JM; Peng, H; Rojas, AL; Yang, H; Zheng, Y | 1 |
| Berger, A; Bischoff, SC; Bitzer, M; Böcker, A; Busch, C; Lauer, UM; Leischner, C; Mayer, M; Noor, S; Schleicher, S; Venturelli, S; Weiland, T; Weiss, TS | 1 |
| Amiri, F; Jeddi-Tehrani, M; Koohdani, F; Vafa, M; Zand, H; Zarnani, AH | 1 |
| Li, J; Li, Y; Liu, M; Wei, M; Zhu, W | 1 |
| Chen, CY; Li, WC; Ting, CT; Tsai, TH | 1 |
| Abudumijiti, H; Chen, K; Chen, R; Dai, W; Guo, C; He, L; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, C; Wang, F; Wang, J; Xia, Y; Xu, L; Yang, J; Yin, Q; Zhang, H; Zhang, R; Zheng, Y; Zhou, L; Zhou, Y; Zhou, Z; Zhu, R | 1 |
| Fürst, R; Kiehl, A; Scherzberg, MC; Stark, H; Stein, J; Steinhilber, D; Ulrich-Rückert, S; Zivkovic, A | 1 |
| Blasi, F; Cossignani, L; Dominici, L; Lombardi, G; Marcotullio, MC; Moretti, M; Vannini, S; Villarini, M | 1 |
| Deng, G; Gao, F; Li, M; Liu, W; Zhou, K | 1 |
| Li, T; Wang, W | 1 |
| Berry, DP; Dennison, AR; Garcea, G; Mann, CD; Manson, MM; Neal, CP | 1 |
| Cao, X; Chen, WQ; Du, LF; Fang, WY; Li, X; Marincola, FM; Stroncek, DF; Wang, E; Worschech, A; Xu, YY; Yang, HL | 1 |
| Choi, HJ; Fukui, M; Zhou, R; Zhu, BT | 1 |
| Bishayee, A; Booth, TD; Hodnichak, CM; Luther, DJ; Meszaros, JG; Ohanyan, V; Shamhart, PE; Sisakian, H | 1 |
| Bishayee, A; Darvesh, AS; Politis, T | 1 |
| Ho, CT; Huang, HW; Weng, CJ; Wu, CF; Wu, CH; Yen, GC | 1 |
| Motiwale, L; Naik, N; Parekh, P; Rao, KV | 1 |
| Barnes, KF; Bhatia, D; Bishayee, A; Chatterjee, M; Darvesh, AS; Mbimba, T; Waghray, A | 1 |
| Khaoustov, V; Yoffe, B | 1 |
| Hamasaki, N; Hiroto, Y; Nakazono, E; Ohnaka, K; Tadokoro, K; Takayanagi, R; Tsuda, H; Tsuda, T | 1 |
| Liao, PC; Lin, CC; Lin, LT; Ng, LT; Richardson, CD; Wang, GH | 1 |
| Egilegor, E; Gallot, N; Mendoza, L; Olaso, E; Salado, C; Valcarcel, M; Vidal-Vanaclocha, F | 1 |
| Berry, DP; Brown, K; Elliott, PJ; Gescher, AJ; Hegarty, B; Hoffmann, E; Howells, LM; Jacobson, EW; Steward, WP | 1 |
| Boylan, JM; Gruppuso, PA; Tatar, M; Villa-Cuesta, E | 1 |
| Deng, S; Du, Q; Hu, B; Shen, KP | 1 |
| Cho, IR; Chung, YH; Horio, Y; Jhun, BH; Koh, SS; Malilas, W; Moon, J; Srisuttee, R | 1 |
| Chiang, LC; Kuo, PL; Lin, CC | 1 |
| Pan, CE; Sun, ZJ; Wu, SL; Yu, L | 1 |
| Meng, KW; Pan, CE; Qin, XL; Sun, ZJ; Wu, SL; Yu, L | 1 |
| Barouki, R; Gouédard, C; Morel, Y | 1 |
| Miura, D; Miura, Y; Yagasaki, K | 1 |
| Brown, J; Le, AD; Lu, QY; Tang, X; Zhang, Q; Zhang, ZF | 1 |
| Ma, AD; Ma, XD; Wang, HJ; Yan, F | 1 |
| Ma, XD; Tian, XM; Yan, F | 1 |
| Cohen, RA; Hou, X; Jiang, B; Maitland-Toolan, KA; Verbeuren, TJ; Wierzbicki, M; Xu, S; Zang, M; Zuccollo, A | 1 |
| Castanas, E; Kampa, M; Kouroumalis, E; Nifli, AP; Notas, G; Vercauteren, J | 1 |
| Feng, L; Jin, J; Tao, WY; Yan, T; Zhang, LF | 1 |
| Bonnesen, C; Stervbo, U; Vang, O | 1 |
| Artur, Y; Chagnon, MC; Delmas, D; Hanet, N; Heydel, JM; Jannin, B; Lançon, A; Latruffe, N; Lizard, G | 1 |
| Kocsis, Z; Marcsek, ZL; Szende, B; Tompa, A | 1 |
| Pan, CE; Wu, WJ; Yu, HB; Zhang, HF; Zhao, SH | 1 |
| Ciolino, HP; Daschner, PJ; Yeh, GC | 1 |
| Kozuki, Y; Miura, Y; Yagasaki, K | 1 |
| Bedin, C; Bioulac-Sage, P; De Lédinghen, V; Desmoulière, A; Krisa, S; Monvoisin, A; Neaud, V; Payrastre, B; Rosenbaum, J | 1 |
| Liu, HS; Pan, CE; Sun, ZJ; Wang, GJ | 1 |
10 review(s) available for resveratrol and Liver Neoplasms
| Article | Year |
|---|---|
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases.
Topics: Antioxidants; Humans; Liver; Liver Neoplasms; NF-kappa B; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Resveratrol; Silybin; Silymarin | 2022 |
Combination Therapy Using Polyphenols: An Efficient Way to Improve Antitumoral Activity and Reduce Resistance.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Catechin; Curcumin; Cytostatic Agents; Doxorubicin; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fluorouracil; Humans; Liver Neoplasms; Polyphenols; Receptors, Estrogen; Resveratrol | 2022 |
Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention.
Topics: Antioxidants; Humans; Liver Neoplasms; Polyphenols; Resveratrol | 2023 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Nanophytomedicine Based Novel Therapeutic Strategies in Liver Cancer.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Catechin; Curcumin; Drug Compounding; Drug Stability; Humans; Liver Neoplasms; Nanocapsules; Plant Extracts; Quercetin; Resveratrol; Solubility; Theranostic Nanomedicine | 2020 |
Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review.
Topics: Carcinoma, Hepatocellular; Chemoprevention; Flavonoids; Humans; Liver Neoplasms; Resveratrol | 2021 |
Treatment for liver cancer: From sorafenib to natural products.
Topics: Antineoplastic Agents; Biological Products; Flavonoids; Ginsenosides; Humans; Immediate-Early Proteins; Liver Neoplasms; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Resveratrol; Sorafenib | 2021 |
Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Topics: Abietanes; Benzylisoquinolines; Berberine; Carcinoma, Hepatocellular; Curcumin; Drugs, Chinese Herbal; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Resveratrol; Scutellaria baicalensis; Stilbenes | 2015 |
Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brassicaceae; Caffeine; Capsaicin; Carcinoma, Hepatocellular; Catechin; Chemoprevention; Curcumin; Flavonoids; Humans; Liver Neoplasms; Phenols; Plant Extracts; Polyphenols; Resveratrol; Stilbenes | 2009 |
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Resveratrol; Stilbenes | 2010 |
3 trial(s) available for resveratrol and Liver Neoplasms
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.
Topics: Aged; Antineoplastic Agents, Phytogenic; Caspase 3; Combined Modality Therapy; Double-Blind Method; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Placebos; Postoperative Complications; Resveratrol; Stilbenes; Titanium | 2011 |
77 other study(ies) available for resveratrol and Liver Neoplasms
| Article | Year |
|---|---|
A resveratrol analog, phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Orchidaceae; Resveratrol; Stilbenes | 2012 |
A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Resveratrol | 2021 |
Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Male; Nanoparticles; Particle Size; Rats; Rats, Wistar; Resveratrol; Solubility | 2021 |
Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2021 |
Inhibition of Liver Cancer Cell Growth by Triethylsilyl Resveratrol through Targeting Phosphoinositide-3 Kinase Pathway.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction | 2021 |
Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; Resveratrol | 2021 |
Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Curcumin; Drug Carriers; Humans; Liver Neoplasms; Nanoparticles; Resveratrol | 2022 |
Resveratrol-Mediated Gold-Nanoceria Synthesis as Green Nanomedicine for Phytotherapy of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cerium; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Nanomedicine; Phytotherapy; Resveratrol | 2022 |
Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Humans; Liver Neoplasms; Resveratrol; Tumor Suppressor Protein p53 | 2022 |
The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress.
Topics: Carcinoma, Hepatocellular; Chlorides; Gallic Acid; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Polyphenols; Resveratrol; Signal Transduction; Sirtuin 1; Telomerase | 2023 |
Efficacy of resveratrol against breast cancer and hepatocellular carcinoma cell lines.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Female; Humans; Liver Neoplasms; Resveratrol | 2023 |
Design, synthesis, and biological evaluation of 1-styrenyl isoquinoline derivatives for anti-hepatocellular carcinoma activity and effect on mitochondria.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Isoquinolines; Liver Neoplasms; Mice; Mitochondria; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol | 2023 |
Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease-related liver cancer by AKT.
Topics: Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Evodia; Humans; Lipid Droplets; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-akt; Quercetin; Resveratrol | 2023 |
Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Hepatocellular; Cisplatin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Hep G2 Cells; Humans; Hydrogels; Kinetics; Liver Neoplasms; Mice; Microspheres; Poloxamer; Resveratrol; Stimuli Responsive Polymers; Temperature | 2020 |
Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; RNA, Small Interfering; Signal Transduction; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2020 |
Resveratrol exerts antitumor effects by downregulating CD8
Topics: Animals; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Liver Neoplasms; Mice; Resveratrol; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2020 |
Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Topics: Animals; Antioxidants; Body Weight; Carcinoma, Hepatocellular; Cations; Cell Death; Drug Carriers; Drug Liberation; Inflammation Mediators; Lipids; Liver; Liver Neoplasms; Male; Nanoparticles; Organ Size; Particle Size; Rats, Wistar; Resveratrol; Static Electricity; Tissue Distribution; Tumor Burden | 2020 |
Pharmacokinetic and Pharmacodynamic Evaluation of Resveratrol Loaded Cationic Liposomes for Targeting Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Liposomes; Liver Neoplasms; Particle Size; Rats; Resveratrol | 2020 |
Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclin D1; Hepatitis B virus; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Repressor Proteins; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Survivin; Trans-Activators; Viral Regulatory and Accessory Proteins | 2017 |
Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.
Topics: Carcinoma, Hepatocellular; Disease Progression; Hep G2 Cells; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liver Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Zinc Finger Protein GLI1 | 2017 |
Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Glycyrrhizic Acid; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Nanoparticles; Resveratrol; Serum Albumin, Human; Stilbenes | 2017 |
Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Endocytosis; Hep G2 Cells; Humans; Liquid Crystals; Liver Neoplasms; Nanoparticles; Particle Size; Resveratrol; Solubility; Stilbenes | 2017 |
A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Proliferation; Combretaceae; Flavonoids; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria; Necrosis; Phenols; Phytotherapy; Plant Extracts; Plant Leaves; Resveratrol; Stilbenes | 2017 |
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Paclitaxel; Resveratrol; RNA, Messenger; Stilbenes | 2017 |
Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Invasiveness; Quercetin; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes | 2018 |
Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Interferon-alpha; Liver Neoplasms; Resveratrol; Signal Transduction; Sirtuins; STAT1 Transcription Factor | 2018 |
Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition.
Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Down-Regulation; Drug Screening Assays, Antitumor; Flow Cytometry; Glutamine; Humans; Liver Neoplasms; Minor Histocompatibility Antigens; Reactive Oxygen Species; Resveratrol; Tumor Cells, Cultured | 2018 |
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Drug Delivery Systems; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Polysaccharides; Resveratrol; Sulfasalazine; Xenograft Model Antitumor Assays | 2018 |
Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
Topics: Adenine; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Benzothiazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Toluene; Tumor Suppressor Protein p53; Up-Regulation | 2018 |
Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Topics: Carcinoma, Hepatocellular; Caspase 3; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Palmitic Acid; Protective Agents; Resveratrol; Sphingolipids; Structure-Activity Relationship; Triglycerides; Tumor Cells, Cultured | 2019 |
Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol
Topics: Apoptosis; Carcinoma, Hepatocellular; Gold; Humans; Liver Neoplasms; Metal Nanoparticles; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2019 |
Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
Topics: Animals; Biological Availability; Biological Transport; Capsules; Cell Proliferation; Drug Carriers; Drug Repositioning; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Rats; Resveratrol; Serum Albumin, Human | 2019 |
The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Signal Transduction; Sp1 Transcription Factor; Stilbenes; Urokinase-Type Plasminogen Activator | 2013 |
Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Avidin; Biotin; Cell Survival; Chitosan; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Nanoparticles; Resveratrol; Stilbenes | 2013 |
Methionine adenosyltransferase 2B, HuR, and sirtuin 1 protein cross-talk impacts on the effect of resveratrol on apoptosis and growth in liver cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; ELAV Proteins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Methionine Adenosyltransferase; Neoplasm Proteins; Resveratrol; RNA Stability; RNA, Messenger; RNA, Neoplasm; Sirtuin 1; Stilbenes | 2013 |
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
Topics: Acetylation; Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Computer Simulation; Hepatoblastoma; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Liver Neoplasms; Molecular Docking Simulation; Resveratrol; Stilbenes | 2013 |
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2013 |
Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Liver Neoplasms; Resveratrol; RNA, Small Interfering; Signal Transduction; Sirtuin 1; STAT3 Transcription Factor; Stilbenes | 2013 |
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
Topics: Aerobiosis; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Growth Processes; Cell Line, Tumor; Glycolysis; Hep G2 Cells; Hexokinase; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Random Allocation; Resveratrol; Stilbenes | 2015 |
Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; HT29 Cells; Humans; Liver Neoplasms; Microtubules; Molecular Structure; Resveratrol; RNA Interference; Sirtuin 1; Stilbenes; Structure-Activity Relationship; Transfection; Tubulin Modulators | 2015 |
In Vitro Safety/Protection Assessment of Resveratrol and Pterostilbene in a Human Hepatoma Cell Line (HepG2).
Topics: Apoptosis; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Liver Neoplasms; Protective Agents; Resveratrol; Stilbenes | 2015 |
Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Knockdown Techniques; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mice, Nude; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-met; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2017 |
[The mechanism of resveratrol on anti-hepatoma Bel-7402 and modulating IL-8 in tumor model mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flow Cytometry; Interleukin-8; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes | 2008 |
Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Caveolin 1; Cell Death; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Drug Synergism; Endocytosis; Genes, Reporter; Humans; Liver Neoplasms; Mice; Mice, Nude; Resveratrol; Sequence Deletion; Stilbenes; Transfection | 2009 |
Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Resveratrol; S Phase; Signal Transduction; Stilbenes | 2009 |
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Topics: Animals; Behavior, Animal; Blotting, Western; Carcinoma, Hepatocellular; Cardiotoxins; Chemoprevention; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Feeding Behavior; Female; Heart; Hepatocytes; Humans; Liver; Liver Neoplasms; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Systole | 2011 |
Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Neoplasm Invasiveness; Resveratrol; Stilbenes | 2010 |
Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
Topics: Anticarcinogenic Agents; Blotting, Western; Cell Proliferation; Cell Survival; Cyclin D1; Down-Regulation; Flow Cytometry; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Microscopy, Confocal; p21-Activated Kinases; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Cyclooxygenase 2; Diethylnitrosamine; Female; HSP70 Heat-Shock Proteins; Humans; Inflammation; Liver; Liver Neoplasms; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Identification of components of grape powder with anti-apoptotic effects.
Topics: Anthocyanins; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Catechin; Cell Death; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; Food, Preserved; Freeze Drying; Fruit; Humans; Liver Neoplasms; Mitochondria, Liver; Oxidative Stress; Quercetin; Reactive Oxygen Species; Resveratrol; Stilbenes; Taurodeoxycholic Acid; Vitis | 2011 |
Resveratrol, a phytoestrogen found in red wine, down-regulates protein S expression in HepG2 cells.
Topics: Blood Proteins; Blotting, Western; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Genistein; Hep G2 Cells; Histocompatibility Antigens; Humans; Liver Neoplasms; Molecular Structure; Phytoestrogens; Promoter Regions, Genetic; Protein C; Protein S; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Structure-Activity Relationship; Time Factors; Transcription, Genetic; Transfection; Wine | 2011 |
Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Down-Regulation; Humans; Inhibitory Concentration 50; Liver Neoplasms; MAP Kinase Signaling System; Resveratrol; S Phase; Stilbenes; Time Factors; Up-Regulation | 2010 |
Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18.
Topics: Animals; Cell Adhesion; Cell Proliferation; Endothelium; Inflammation; Interleukin-18; Liver; Liver Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microvessels; Models, Biological; Neoplasm Transplantation; Resveratrol; Stilbenes; Tumor Microenvironment; Vascular Cell Adhesion Molecule-1 | 2011 |
Resveratrol inhibits protein translation in hepatic cells.
Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Enzyme Activation; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4F; Liver; Liver Neoplasms; Phosphorylation; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Transcription Factors | 2011 |
[Effects of resveratrol on apoptosis and ROS production in Hepa 1-6 hepatocarcinoma cells].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Liver Neoplasms; Mice; Plants, Medicinal; Reactive Oxygen Species; Resveratrol; Stilbenes | 2012 |
SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis.
Topics: Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Humans; Liver Neoplasms; MAP Kinase Kinase 4; Oxidative Stress; Phosphorylation; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; Trans-Activators; Up-Regulation; Viral Regulatory and Accessory Proteins | 2012 |
Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; fas Receptor; Growth Inhibitors; Humans; Kinetics; Liver Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Cycle Proteins; Cyclin B; Cyclin B1; Cyclin D1; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Resveratrol; Stilbenes | 2003 |
Effect of resveratrol and in combination with 5-FU on murine liver cancer.
Topics: Animals; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle Proteins; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Resveratrol; Stilbenes; Survival Rate | 2004 |
Induction of the paraoxonase-1 gene expression by resveratrol.
Topics: Aryldialkylphosphatase; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chromosome Mapping; Enzyme Induction; Estrogen Receptor alpha; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Liver Neoplasms; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Response Elements; Resveratrol; Stilbenes; Transcriptional Activation; Transfection; Xenobiotics | 2004 |
Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.
Topics: Animals; Carcinoma, Hepatocellular; Free Radical Scavengers; Gene Expression; Hepatocyte Growth Factor; Hypoxanthine; Liver Neoplasms; Male; Neoplasm Invasiveness; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2004 |
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Stilbenes; Tongue Neoplasms; Transcriptional Activation; Vascular Endothelial Growth Factors | 2005 |
[Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Membrane Potentials; Mitochondrial Membranes; Resveratrol; Stilbenes | 2006 |
[Effects of resveratrol on growth inhibition and gap-junctional intercellular communication of HepG2 cells].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Communication; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gap Junctions; Humans; Liver Neoplasms; Resveratrol; S Phase; Stilbenes | 2006 |
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Apigenin; Atherosclerosis; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enzyme Activation; Flavonoids; Glucose; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multienzyme Complexes; Phenols; Phosphorylation; Polyphenols; Protein Serine-Threonine Kinases; Receptors, LDL; Resveratrol; Stilbenes | 2006 |
Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; G1 Phase; G2 Phase; Humans; Liver Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Resveratrol; Stilbenes; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2006 |
[Studies on active substance of anticancer effect in Polygonum cuspidatum].
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial Cells; Fallopia japonica; Female; Humans; Liver Neoplasms; Plants, Medicinal; Rats; Resveratrol; Rhizome; Stilbenes | 2006 |
Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells.
Topics: Annexin A5; Anticarcinogenic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Nucleus Size; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Resveratrol; Stilbenes; Thymidine; Tritium | 2006 |
Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Induction; Enzymes; Flow Cytometry; Glucuronosyltransferase; Humans; Liver Neoplasms; Mass Spectrometry; Metabolic Detoxication, Phase II; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Sulfotransferases; Time Factors; Tritium | 2007 |
Effect of formaldehyde and resveratrol on the viability of Vero, HepG2 and MCF-7 cells.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Disinfectants; Formaldehyde; Liver Neoplasms; Receptors, Estrogen; Resveratrol; Stilbenes; Vero Cells | 2007 |
[Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Resveratrol; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2008 |
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Cytosol; Humans; Liver Neoplasms; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 1998 |
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Hepatocellular; Cell Division; Hypoxanthine; Liver Neoplasms; Neoplasm Invasiveness; Rats; Resveratrol; Stilbenes; Tumor Cells, Cultured; Xanthine Oxidase | 2001 |
Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Flavonoids; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Phenols; Phosphorylation; Poly(ADP-ribose) Polymerases; Polymers; Polyphenols; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA, Messenger; Stilbenes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |
Anti-hepatoma activity of resveratrol in vitro.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Humans; In Vitro Techniques; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2002 |